Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats

References

• Jones G, Nash P, Hall S. Advances in rheumatoid arthritis. Med J Aust. 2017;206:221–224.
   PubMed Web of Science ®Google Scholar
• Al-Zifzaf DS, El Bakry SA, Mamdouh R, et al. FoxP3+ T regulatory cells in rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis. Egypt Rheumatol. 2015;37:7–15.
   Web of Science ®Google Scholar
• Hu Y, Cheng W, Cai W, et al. Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol. 2013;32:161–165.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511.
   PubMed Web of Science ®Google Scholar
• Iwahashi M, Yamamura M, Aita T, et al. Expression of toll‐like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheumatol. 2004;50:1457–1467.
   PubMed Web of Science ®Google Scholar
• Zhu W, Meng L, Jiang C, et al. Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts. Arthritis Res Ther. 2011;13:R103.
   PubMed Web of Science ®Google Scholar
• Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277:15028–15034.
   PubMed Web of Science ®Google Scholar
• Schaefer L, Babelova A, Kiss E, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005;115:2223.
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Semin Immunol. 2004;16:35–41.
   PubMed Web of Science ®Google Scholar
• Chang EH, Harford JB, Eaton MA, et al. Nanomedicine: past, present and future – a global perspective. Biochem Biophys Res Commun. 2015;468:511–517.
   PubMed Web of Science ®Google Scholar
• Indana MK, Gangapuram BR, Dadigala R, et al. A novel green synthesis and characterization of silver nanoparticles using gum tragacanth and evaluation of their potential catalytic reduction activities with methylene blue and Congo red dyes. J Anal Sci Technol. 2016;7:19.
   Web of Science ®Google Scholar
• Brown PK, Qureshi AT, Moll AN, et al. Silver nanoscale antisense drug delivery system for photoactivated gene silencing. ACS Nano. 2013;7:2948–2959.
   PubMed Web of Science ®Google Scholar
• Rao K, Imran M, Jabri T, et al. Gum tragacanth stabilized green gold nanoparticles as cargos for Naringin loading: a morphological investigation through AFM. Carbohydr Polym. 2017;174:243–252.
   PubMed Web of Science ®Google Scholar
• Grein A, da Silva BC, Wendel CF, et al. Structural characterization and emulsifying properties of polysaccharides of Acacia mearnsii de Wild gum. Carbohydr Polym. 2013;92:312–320.
   PubMed Web of Science ®Google Scholar
• Upadhyay RK. Nutritional, therapeutic, and pharmaceutical potential of plant gums: a review. Int J Green Pharm. 2017;11:S30–S48.
   Google Scholar
• Li R, Li J, Cai L, et al. Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms. J Pharm Pharmacol. 2008;60:221–228.
   PubMed Web of Science ®Google Scholar
• Umar S, Kumar A, Sajad M, et al. Hesperidin inhibits collagen-induced arthritis possibly through suppression of free radical load and reduction in neutrophil activation and infiltration. Rheumatol Int. 2013;33:657–663.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun Z, Xu D, et al. Hesperidin derivative-11 inhibits fibroblast-like synoviocytes proliferation by activating Secreted frizzled-related protein 2 in adjuvant arthritis rats. Eur J Pharmacol. 2017;794:173–183.
   PubMed Web of Science ®Google Scholar
• Baizabal-Aguirre VM. Cross-talk mechanisms of Wnt/beta-catenin signaling components with TLR-activated signaling molecules in the inflammatory response. Front Immunol. 2017;8:1396.
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr. 2010;91:940–949.
   PubMed Web of Science ®Google Scholar
• Sansone F, Rossi A, Del Gaudio P, et al. Hesperidin gastroresistant microparticles by spray-drying: preparation, characterization, and dissolution profiles. AAPS Pharmscitech. 2009;10:391–401.
   PubMed Web of Science ®Google Scholar
• Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956;91:95–101.
   PubMed Web of Science ®Google Scholar
• Quan L-d, Thiele GM, Tian J, et al. The development of novel therapies for rheumatoid arthritis. Expert Opin Ther Pat. 2008;18:723–738.
   PubMed Web of Science ®Google Scholar
• Dewangan AK, Perumal Y, Pavurala N, et al. Preparation, characterization and anti-inflammatory effects of curcumin loaded carboxymethyl cellulose acetate butyrate nanoparticles on adjuvant induced arthritis in rats. J Drug Deliv Sci Technol. 2017;41:269–279.
   Web of Science ®Google Scholar
• Laukova M, Vargovic P, Rokytova I, et al. Repeated stress exaggerates lipopolysaccharide-induced inflammatory response in the rat spleen. Cell Mol Neurobiol. 2018;38:195–208.
   PubMed Web of Science ®Google Scholar
• Perveen K, Hanif F, Jawed H, et al. N-(2-hydroxy phenyl) acetamide: a novel suppressor of Toll-like receptors (TLR-2 and TLR-4) in adjuvant-induced arthritic rats. Mol Cell Biochem. 2014;394:67–75.
   PubMed Web of Science ®Google Scholar
• Thakur M, Pandey S, Mewada A, et al. Understanding the stability of silver nanoparticles bio-fabricated using Acacia arabica (Babool gum) and its hostile effect on microorganisms. Spectrochim Acta A Mol Biomol Spectrosc. 2013;109:344–347.
   PubMed Web of Science ®Google Scholar
• Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76–83.
   PubMed Web of Science ®Google Scholar
• Pooja D, Panyaram S, Kulhari H, et al. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydr Polym. 2014;110:1–9.
   PubMed Web of Science ®Google Scholar
• Imran M, Shah MR, Ullah F, et al. Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime. Artif Cells Nanomedicine Biotechnol. 2016;45:1440–1451.
   PubMed Web of Science ®Google Scholar
• Akele ML, Assefa AG, Alle M. Microwave-assisted green synthesis of silver nanoparticles by using gum acacia: synthesis, characterization and catalytic activity studies. Int J Green Chem Bioprocess. 2015;5:21–27.
   Google Scholar
• Venkatesham M, Ayodhya D, Madhusudhan A, et al. Synthesis of stable silver nanoparticles using gum acacia as reducing and stabilizing agent and study of its microbial properties: a novel green approach. Int J Green Nanotechnol. 2012;4:199–206.
   Google Scholar
• Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86:215–223.
   PubMed Web of Science ®Google Scholar
• Dhar S, Reddy EM, Shiras A, et al. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chemistry. 2008;14:10244–10250.
   PubMed Web of Science ®Google Scholar
• Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1:377–385.
   PubMedGoogle Scholar
• Bendele A. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact. 2001;1:363–376.
   PubMedGoogle Scholar
• Bendele A, Mccomb J, Gould T, et al. Animal models of arthritis: relevance to human disease. Toxicol Pathol. 1999;27:134–142.
   PubMed Web of Science ®Google Scholar
• Coulombe F, Divangahi M, Veyrier F, et al. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med. 2009;206:1709–1716.
   PubMed Web of Science ®Google Scholar
• Kanagawa H, Niki Y, Kobayashi T, et al. Mycobacterium tuberculosis promotes arthritis development through toll-like receptor 2. J Bone Miner Metab. 2015;33:135–141.
   PubMed Web of Science ®Google Scholar
• Hu F, Li Y, Zheng L, et al. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis. PLoS One. 2014;9:e100266.
   PubMed Web of Science ®Google Scholar
• Brentano F, Kyburz D, Gay S. Toll-like receptors and rheumatoid arthritis. In: McCoy, CE, O'Neill, editors. Toll-like receptors: methods and protocols. New York: Humana Press; 2009. p. 329–343.
   Google Scholar
• Guardia T, Rotelli AE, Juarez AO, et al. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco. 2001;56:683–687.
   PubMedGoogle Scholar
• Kawaguchi K, Maruyama H, Kometani T, et al. Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin. Planta Med. 2006;72:477–479.
   PubMed Web of Science ®Google Scholar
• Bua S, Di Cesare Mannelli L, Vullo D, et al. Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs–CAIs) for the treatment of rheumatoid arthritis. J Med Chem. 2017;60:1159–1170.
   PubMed Web of Science ®Google Scholar
• Bickham K, Kivitz AJ, Mehta A, et al. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC Musculoskelet Disord. 2016;17:331.
   PubMed Web of Science ®Google Scholar
• Newman N, Ling R. Acetabular bone destruction related to non-steroidal anti-inflammatory drugs. Lancet. 1985;2:11–14.
   PubMed Web of Science ®Google Scholar
• Gonzalez‐Juanatey C, Testa A, Garcia‐Castelo A, et al. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti-tumor necrosis factor α antibody. Arthritis Rheum. 2004;51:447–450.
   PubMed Web of Science ®Google Scholar
• Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343:1586–1593.
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26–37.
   PubMed Web of Science ®Google Scholar
• Caporali R, Caprioli M, Bobbio-Pallavicini F, et al. Long term treatment of rheumatoid arthritis with rituximab. Autoimmun Rev. 2009;8:591–594.
   PubMed Web of Science ®Google Scholar
• Castillo J, Milani C, Mendez-Allwood D. Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders. Expert Opin Investig Drugs. 2009;18:491–500.
   PubMed Web of Science ®Google Scholar
• Chen G, Roy I, Yang C, et al. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem Rev. 2016;116:2826–2885.
   PubMed Web of Science ®Google Scholar
• O'neill LA. Primer: toll-like receptor signaling pathways – what do rheumatologists need to know? Nat Clin Pract Rheumatol. 2008;4:319–327.
   PubMedGoogle Scholar
• Kattumuri V, Katti K, Bhaskaran S, et al. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X‐ray‐contrast‐imaging studies. Small. 2007;3:333–341.
   PubMed Web of Science ®Google Scholar
• Ganeshkumar M, Ponrasu T, Raja MD, et al. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery. Spectrochim Acta AMol Biomol Spectrosc. 2014;130:64–71.
   PubMed Web of Science ®Google Scholar